Literature DB >> 15379422

Should the duration of the insulin tolerance test be shortened to 90 minutes?

Somchit Jaruratanasirikul1, Kalaya Leethanaporn, Hutcha Sriplung.   

Abstract

The insulin tolerance test (ITT) is a standard growth hormone (GH) provocative test to distinguish children with normal variant short stature (NVSS) from those with GH deficiency (GHD). We reviewed ITTs retrospectively in 52 short children using peak GH concentration of 7 ng/ ml as a cut-off level for GHD (peak GH <7 ng/ ml) and NVSS (peak GH > or =7 ng/ml). The average insulin dosage was 0.1 U/kg in children with NVSS and 0.08 U/kg in GHD. Hypoglycemia was achieved in all cases with an average plasma glucose nadir of 1.8 mmol/l (32 mg/dl) occurring between 15 and 45 min following administration. The average peak GH concentration was 12 ng/ml, occurring at 30-90 min. There were no serious adverse effects from the ITT. We conclude that the appropriate duration of ITT should be 90 minutes. The appropriate timing to obtain samples for plasma glucose level is at 0, 15, 30, 45, 60, and 90 min, and for GH concentrations at 0, 30, 45, 60, and 90 min. The shortened duration of ITT to 90 min will reduce the time spent and also the financial cost for unnecessary samples, while still ensuring a correct diagnosis for the patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379422     DOI: 10.1515/jpem.2004.17.8.1105

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  A Comparison of the Blood Glucose, Growth Hormone, and Cortisol Responses to Two Doses of Insulin (0.15 U/kg vs. 0.10 U/kg) in the Insulin Tolerance Test: A Single-Centre Audit of 174 Cases.

Authors:  Phillip Yeoh; Andrew A Dwyer; Ella Anghel; Pierre M Bouloux; Bernard Khoo; Shern Chew; Florian Wernig; Paul Carroll; Simon J B Aylwin; Stephanie E Baldeweg; William Drake; Jeannie Todd; Lindiwe Mangena; Ashley Grossman
Journal:  Int J Endocrinol       Date:  2022-02-08       Impact factor: 2.803

Review 2.  Growth Hormone Stimulation Testing: To Test or Not to Test? That Is One of the Questions.

Authors:  Mabel Yau; Robert Rapaport
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.